2011 Future Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies Contains two volumes, over 2,000 pages and 800 tables Includes a 750-page Worldwide Market and Technology Overview VENTURE PLANNING GROUP WWW.VPGCORP.COM EMERGING OPPORTUNITIES AND BUSINESS STRATEGIES FRANCE GERMANY ITALY JAPAN SPAIN UK USA V P G I N F O R M AT I O N • I N T E L L I G E N C E • A N A LY S I S • I N S I G H T FRANCE GERMANY ITALY JAPAN SPAIN UK USA MEDICAL DEVICES PHARMACEUTICALS CHEMICALS FOOD & BEVERAGE ELECTRONICS
103
Embed
MEDICAL DEVICES PHARMACEUTICALS …...MARKET SHARE ANALYSIS The report provides the 2010 sales and market share estimates for major suppliers of infectious disease reagent kits by
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
2011 Future Infectious Disease Testing Market:
Growth Opportunities and Business Expansion Strategies
Contains two volumes, over 2,000 pages and 800 tables
Includes a 750-page Worldwide Market and Technology Overview
VENTURE PLANNING GROUP W W W. V P G C O R P. C O M
EMERGING OPPORTUNITIES
AND BUSINESS STRATEGIES
FRANCE
GERMANY
ITALY
JAPAN
SPAIN
UK
USA
V P GI N F O R M AT I O N • I N T E L L I G E N C E • A N A LYS IS • I N S I G H T
FRANCE GERMANY ITALYJAPANSPAIN UK USA
MEDICAL DEVICES PHARMACEUTICALS CHEMICALS FOOD & BEVERAGE ELECTRONICS
The 2011 Infectious Disease Testing Market Emerging Opportunities and Business Strategies
FRANCE GERMANY ITALY JAPAN SPAIN U.K. U.S.A.
CONTAINS OVER 2,000 PAGES AND 800 TABLES
RATIONALE The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry and the greatest challenge facing suppliers in the 21st century. Among the main driving forces behind the growth of this dynamic market is the spread of AIDS, which remains the world’s major health threat and the key factor contributing to the rise in incidence of opportunistic infections, threat of bioterrorism, advances in molecular diagnostic technologies and a wider availability of immunosupressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
This comprehensive worldwide survey is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report includes a market segmentation analysis of over 90 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.
REPORT CONTENT COUNTRY COVERAGE The study presents detailed analyses of the infectious disease testing markets in the following seven countries: - FRANCE - GERMANY - ITALY - JAPAN - SPAIN - U.K. - U.S.A.
In addition to individual country assessments, a 750-page worldwide market overview is provided. The analysis of each country includes the following information:
BUSINESS DYNAMICS AND TRENDS In this section, the potential market impact of major technological, economic, regulatory, demographic and social trends is explored. The study also presents the scientific views on the definition, epidemiology and etiology of major infectious diseases.
MAJOR MARKET SEGMENTS A detailed analysis, including 5- and 10-year test volume and diagnostics sales forecast for the following market is presented: - Hospitals - Public Health Laboratories - Commercial/Private Laboratories - Blood Banks - Physician Offices/Group Practices - Ambulatory Care Centers
MARKET SIZE AND GROWTH, 2010-2020 For each assay and market segment, the study provides the 2010, 2015 and 2020 test volume and sales forecasts.
MARKET SHARE ANALYSIS The report provides the 2010 sales and market share estimates for major suppliers of infectious disease reagent kits by individual test.
TECHNOLOGICAL ASSESSMENT For the following technologies, the study examines current and potential applications for the infectious disease testing during 2011-2020. - Automation - Differential light scattering - Gel microdroplets - Artificial intelligence - Flow cytometry - Molecular diagnostics - Chromatography - Immunoassays - Monoclonal antibodies, and others
MARKET NEEDS AND CHALLENGES The study identifies the major opportunities for infectious disease reagent kits and instruments facing suppliers during 2011-2020 and proposes “ideal” product models with tentative operating characteristics and prices.
MARKET PARTICIPANTS Insightful profiles of leading suppliers and recent market entrants developing innovative technologies and products are presented. The 2010 sales performance, product portfolios, anticipated new product introductions, marketing strategies and collaborative arrangements are analyzed.
NEW PRODUCT OPPORTUNITIES & BUSINESS GROWTH STRATEGIES - Business expansion opportunities. - Market entry barriers and risks. - Alternative marketing strategies. - Strategic planning issues and concerns.
METHODOLOGY The study is based on a combination of primary and secondary information sources, including a comprehensive worldwide survey of technical and business periodicals, manufacturer product and financial literature, and industry analyst. Additional information was retrieved from VENTURE PLANNING GROUP’s proprietary files developed during the firm’s over 100 syndicated studies andnumerous single -client assignments. This database contains current information on various healthcare and biotechnology markets, technologies, companies, products and executives worldwide.
INFECTIOUS DISEASES TESTING MARKET: US, Europe, JapanEmerging Opportunities and Business Strategies
Published by Venture Planning Groupwww.VPGMarketResearch.com
Table of Contents
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests 1. AIDS a. Background
0 Structure and Composition0 Classification0 Origin of AIDS0 Animal Lentivirus Systems0 Virus Receptos0 HIV Infections in Humans - Pathogenesis & Pathology: Overview of HIV Infection Course0 CD4T Lymphocytes and Memory Cells0 Monocytes and Macrophages0 Lymphoid Organs0 Neural Cells0 Viral Coinfections - Clinical Findings0 Plasma Viral Load0 Pediatric AIDS - Neurologic Disease - Opportunistic Infections - Cancer0 Immunity - Virus Isolation - Serology - Detection of Viral Nucleic Acid and Antigens0 Infectivity0 Epidemiology - Worldwide Spread of AIDS - United States - Routes of Transmission
Table of Contents (continued)
b. Diagnostic Tests0 Laboratory Diagnosis - Enzyme Immunoassay Interpretation - Specific, Sensitivity, and Predictive
Value of Enzyme Immunoassays0 Competition Assays0 Western Blot Technique0 Immuno-Fluorescence Assay (IFA)0 Radioimmunoprecipitation0 HIV-1/HIV-2 Combination Testing0 Methods of HIV-Antigen Detection0 Antigen Assays and Blood Screening0 Urine Tests0 Immunopathogenic Mechanism of HIV Infection 0 DNA Probes - Overview - Quantitative Polymerase Chain Reaction - In Situ PCR
- Disease Sciences/Bio Tec Global - Imperial College of Medicine - Ortho-Clinical Diagnostics - Pall - ProMetic Life Sciences - Proteome Sciences/Idexx - Q-One Biotech - Serono - U.S. Agricultural Research Service
b. Diagnostic Tests0 Viral Isolation and Identification0 Antibody Tests
c. Vaccines and Drugs 27. Epstein-Barr Virus
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 28. Giardia Lamblia
a. Background0 Life Cycle and Morphology0 Morphology of Trophozoites0 Clinical Disease
b. Diagnostic Tests c. Vaccines and Drugs
Table of Contents (continued)
29. Gonorrhea a. Background
b. Diagnostic Tests c. Vaccines and Drugs
30. Granuloma Inguinale a. Background
b. Diagnostic Tests c. Vaccines and Drugs
31. Hantavirus a. Background
0 Identification of the Agent0 Transmission0 Other Rodent Hantaviruses0 Distribution0 Hantavirus Diseases0 Epidemiology0 Addendum in Proof-Northeastern Connection0 Previously Unknown Pathogens0 Cases Nationwide
b. Diagnostic Tests0 An Immunohistochemistry Approach0 Hantavirus Rapid Diagnostic Test0 ELISA Diagnosis of Hantavirus Pulmonary Syndrome0 IgG ELISA0 IgM Capture ELISA
c. Vaccines and Drugs 32. Helicobacter Pylori
a. Background0 Pathogenesis0 Role in Peptic Ulcer Disease0 Role in Gastric Cancer0 Nonulcer Dyspepsia
b. Diagnostic Tests c. Vaccines and Drugs
0 Specific Therapeutic Regimens0 Who Should Be Treated?0 Participants in Controlled Clinical Trials
Table of Contents (continued)
0 Patients with Refractory Peptic Ulcer0 Patients with Refractory NUD0 Patients in High-Risk Groups for Gastric Cancer
33. Hepatitis a. Background b. Hepatitis A c. Hepatitis B d. Hepatitis C
0 Classification0 Transmission of Infection0 Occupational Hazards0 Acute Hepatitis0 Diagnosis of Acute Infection0 Chronic Hepatitis0 HCV and Other Chronic Liver Diseases0 Alcoholic Liver Disease0 Hepatitis B Coinfection0 Cirrhosis and Hepatocellular Carcinoma0 Diagnostic Tests0 Possible Indications for HCV RNA Testing0 Conclusions and Future Direction
e. Hepatitis D0 Historical Perspective0 Epidemiology0 HBV-HDV "Coinfection" vs. "Superinfection"0 Methods of Detecting HDV0 Prevention
f. Hepatitis E0 Background0 Prevalence of the Disease0 Diagnostic Tests0 Epidemiologic Serosurveys0 Serologic Cross-Reactivity
g. Hepatitis G 0 Vaccines and Drugs
34. Herpes Simplex Virus a. Background b. Diagnostic Tests c. Vaccines and Drugs
Table of Contents (continued)
35. Human Herpes Virus-6 (HHV-6) a. Background
0 HIV-6 Infections b. Diagnostic Tests c. Vaccines and Drugs
36. Influenza Viruses a. Background
b. Diagnostic Tests c. Vaccines and Drugs
37. Legionella a. Background
b. Diagnostic Tests c. Vaccines and Drugs
38. Lyme Disease a. Background
0 Clinical Description0 Clinical Case Definition0 Laboratory Criteria for Diagnosis0 Case Classification
b. Diagnostic Tests c. Vaccines and Drugs 39. Lymphogranuloma Venereum (LGV)
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 40. Malaria
a. Background b. Diagnostic Tests
0 Potential Diagnostic Problems with Positive Patients from Non-endemic Areas - Patient - Laboratory - Physician
c. Vaccines and Drugs 41. Measles (Rubeola)
a. Background b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
42. Meningitis a. Background
b. Diagnostic Tests c. Vaccines and Drugs
0 Development of Polysaccharide Vaccines0 Quadrivalent Vaccine Development0 Meningococcal A.C.Y. & W-135 Vaccines0 Efficacy of Group C Vaccine0 Efficacy of Group A Vaccine0 Combinations of Group A and C Vaccines0 Group B Efficacy Trials0 Future Direction
43. Microsporidium a. Background
0 Prevalence and Geographic Distribution0 Sources of Human Infection and Transmission
b. Diagnostic Tests0 Light Microscopic Examination of Stool Specimens By Chromotrope Staining0 Stool Concentration Methods0 Chemofluorescent Agents0 Giemsa Staining of Stool Specimens0 Cytologic Diagnosis0 Histologic Examination0 Electron Microscopy0 Examination of Bodily Fluids0 Examination of Tissue Sections0 Immunofluorescence Detection Procedures0 Serology0 Cell Culture0 Approach to Diagnosis0 Evaluation of Patients with Presumptive Intestinal Microsporidiosis0 Evaluation of Patients with Presumptive Ocular Microsporidiosis
c. Vaccines and Drugs 44. Mononucleosis
a. Background b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
45. Mumps a. Background
b. Diagnostic Tests c. Vaccines and Drugs
0 Efficacy of Vaccination0 Future Issues
46. Mycoplasma a. Background
0 Ureaplasma Urealyticum & Mycoplasma Hominis b. Diagnostic Tests
c. Vaccines and Drugs 47. Papillomaviruses
a. Background0 HPV in Cancer0 Cervical Neoplasm
b. Diagnostic Tests c. Vaccines and Drugs
0 Prevention 48. Parvovirus B19
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 49. Pneumonia
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 50. Polyomaviruses
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 51. Pseudomonas Aeruginosa
a. Background0 Virulence Factors
b. Diagnostic Tests c. Vaccines and Drugs 52. Rabies
a. Background b. Diagnostic Tests
c. Vaccines and Drugs
Table of Contents (continued)
53. Respiratory Syncytial Virus (RSV) a. Background
b. Diagnostic Tests c. Vaccines and Drugs
54. RhinoViruses a. Background
b. Diagnostic Tests c. Vaccines and Drugs
55. RotaVirus (REOVIRUS) a. Background
b. Diagnostic Tests c. Vaccines and Drugs 56. Rubella(MEASLES)
a. Background b. Diagnostic Tests
c. Vaccines and Drugs0 Developing Countries0 Elimination and Eradication of Measles0 New Developments
57. Salmonellosis a. Background
b. Diagnostic Tests c. Vaccines and Drugs 58. Septicemia
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 59. Shigellosis a. Background
b. Diagnostic Tests c. Vaccines and Drugs
60. Staphylococcus Aureus a. Background
0 The Genus Taphylococcus b. Diagnostic Tests
c. Vaccines and Drugs 0 Prevention
61. Streptococci a. Background b. Diagnostic Tests
Table of Contents (continued)
c. Vaccines and Drugs0 Group A Streptococci0 Group B Streptococci
62. Syphilis a. Background b. Diagnostic Tests
0 Biopsy0 Rabbit Infectivity Testing0 Other Diagnostic Modalities
c. Vaccines and Drugs0 Syphilis and HIV Infection0 Syphilis As a Cofactor for HIV Transmission0 Basic Science Issues
63. Toxoplasmosis a. Background b. Diagnostic Tests
c. Vaccines and Drugs 64. Trichomonas Vaginalis
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 65. Tuberculosis
a. Background b. Diagnostic Tests
0 Microscopic Characteristics0 Cultural Characteristics0 Detection of Antibodies0 Skin Tests0 MDRTB
c. Vaccines and Drugs 66. Vibrio
a. Background b. Diagnostic Tests
c. Vaccines and Drugs 67. West Nile Virus
a. Background - Clinical Syndromes
b. Diagnostic Tests c. Vaccines and Drugs
Table of Contents (continued)
68. Yersina a. Background b. Diagnostic Tests
c. Vaccines and Drugs B. Instrumentation Review and Market Needs
D. Business Environment E. Market Structure F. Market Size and Growth G. Personal Testing
Table of Contents (continued)
France A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers
Germany A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers
Italy A. Executive Summary B. Business Environment C. Market Structure
D. Market Size, Growth and Major Suppliers
Japan A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Suppliers
Spain A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth And Major Suppliers
U.K. A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth a+nd Major Suppliers
U.S.A. A. Executive Summary B. Business Environment
1. Health Care Expenditures
Table of Contents (continued)
2. Cost Consciousness3. Reimbursement4. Industry Consolidation5. Managed Care a. HMO b. PPO
6. Hospitals 7. Admissions
8. Length of Stay9. Industry Diversification
10. Physician Demographics 11. Population Aging
a. Chronic Illness b. Disease Incidence c. Susceptibility to Iatrogenesis d. Multiple Illness Cases
12. Laboratory Regulations 13. FDA Reform
C. Market Structure1. Centralized Testing a. Hospitals b. Commercial/Private Laboratories c. Blood Banks
1) Community and Regional Centers 2) Plasma Fractionation Centers
2. Decentralized Testing a. Physician Offices/Group Practices b. Point of Care Testing c. Other Decentralized Testing Locations
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation B. Reagent Kits and Test Systems/panels C. Computers, Software and Automation D. Auxiliary Products
Table of Contents (continued)
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development B. Collaborative Arrangements C. University Contracts D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches 2. Product Complexity 3. Customer Preference 4. Established Suppliers 5. Emerging Suppliers 6. Major Types of Distributors 7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection F. Regulatory Constraints G. Decentralized Testing Market Challenges
FranceHIV or HIVI/HIVII Test Volume and Diagnostics Sales ForecastForecast by Market Segment
List of Tables (continued)
FranceHTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market Segment
FranceHIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
FranceWestern Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
FranceAdenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceAeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
FranceBEA Test Volume and Diagnostics Sales Forecast by Market Segment
FranceBlastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceCampylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
FranceCandida Test Volume and Diagnostics Sales Forecast by MarketSegment
FranceChancroid Test Volume and Diagnostics Sales Forecast by Market Segment
List of Tables (continued)
FranceChlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
FranceClostridium Test Volume and Diagnostics Sales Forecastby Market Segment
FranceCryptosporidium Test Volume and Diagnostics Sales Forecastby Market Segment
FranceCMV Test Volume and Diagnostics Sales Forecast by Market Segment
FranceE. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
FranceEchovirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceEnterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceEBV Test Volume and Diagnostics Sales Forecast by Market Segment
FranceGiardia Test Volume and Diagnostics Sales Forecast by MarketSegment
FranceGonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
List of Tables (continued)
FranceGranuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHelicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
FranceAnti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
FranceAnti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
FranceAnti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHepatitis Delta Test Volume and Diagnostics Sales Forecastby Market Segment
FranceHBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
List of Tables (continued)
FranceHBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
FranceALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHerpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
FranceHerpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
FranceInfluenza Test Volume and Diagnostics Sales Forecast by Market Segment
FranceLegionella Test Volume and Diagnostics Sales Forecast by Market Segment
FranceLyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
FranceLymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
FranceMalaria Test Volume and Diagnostics Sales Forecast by Market Segment
FranceMeasles Test Volume and Diagnostics Sales Forecast by Market Segment
List of Tables (continued)
FranceMeningitis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceMicrosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
FranceMononucleosis Test Volume and Diagnostics Sales Forecast byMarket Segment FranceMumps Test Volume and Diagnostics Sales Forecast by Market Segment
FranceMycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
FrancePapilloma Virus Test Volume and Diagnostics SalesForecast by Market Segment
FranceParvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
FrancePneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
FrancePolioma Viruses Test Volume and Diagnostics Sales Forecast byMarket Segment
FrancePseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
List of Tables (continued)
FranceRabies Test Volume and Diagnostics Sales Forecast by Market Segment FranceRSV Test Volume and Diagnostics Sales Forecast by Market Segment
FranceRheumatoid Arthritis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceRhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceRotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
FranceRubella Test Volume and Diagnostics Sales Forecast by Market Segment
FranceSalmonella Test Volume and Diagnostics Sales Forecast by Market Segment
FranceScleroderma Test Volume and Diagnostics Sales Forecast by Market Segment
FranceSepticemia Test Volume and Diagnostics Sales Forecast by Market Segment
FranceShigella Test Volume and Diagnostics Sales Forecast by MarketSegment
List of Tables (continued)
FranceStaphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
FranceStreptococci Test Volume and Diagnostics Sales Forecast by Market Segment
FranceSyphilis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceToxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceTrichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
FranceTuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
FranceVibrio Test Volume and Diagnostics Sales Forecast by MarketSegment
FranceYersinia Test Volume and Diagnostics Sales Forecast by MarketSegment
FranceAIDS Testing Market Diagnostics Sales by Major Supplier
FranceAdenovirus Testing Market Diagnostics Sales by Major Supplier
List of Tables (continued)
FranceCampylobacter Testing Market Diagnostics Sales by Major Supplier
FranceCandida Testing Market Diagnostics Sales by Major Supplier
FranceChlamydia Testing Market Diagnostics Sales by MajorSupplier
FranceCMV Testing Market Diagnostics Sales by Major Supplier
FranceGonorrhea Testing Market Diagnostics Sales by MajorSupplier
FranceHepatitis Testing Market Diagnostics Sales by MajorSupplier
FranceHepatitis C Testing Market Diagnostics Sales by Major Supplier
FranceHerpes Testing Market Diagnostics Sales by Major Supplier
FranceLyme Disease Testing Market Diagnostics Sales by Major Supplier
FranceMeningitis Testing Market Diagnostics Sales by Major Supplier
List of Tables (continued)
FranceMononucleosis Testing Market Diagnostics Sales by Major Supplier
FranceMumps Testing Market Diagnostics Sales by Major Supplier
FranceMycoplasma Testing Market Diagnostics Sales by MajorSupplier
FranceRSV Testing Market Diagnostics Sales by Major Supplier
FranceRheumatoid Arthritis Testing Market Diagnostics Sales by Major Supplier
FranceRotavirus Testing Market Diagnostics Sales by MajorSupplier
FranceRubella Testing Market Diagnostics Sales by Major Supplier
FranceSepticemia Testing Market Diagnostics Sales by MajorSupplier
FranceShigella Testing Market Diagnostics Sales by Major Supplier
FranceStreptococci Testing Market Diagnostics Sales by Major Supplier
List of Tables (continued)
FranceSyphilis Testing Market Diagnostics Sales by Major Supplier
FranceToxoplasmosis Testing Market Diagnostics Sales by Major Supplier
FranceTrichomonas Testing Market Diagnostics Sales by Major Supplier
France Tuberculosis Testing Market Diagnostics Sales by Major Supplier
FranceInfectious Disease Diagnostic Testing InstrumentationMajor Systems Estimated Placements and Installed Base
Germany Summary TableAll Infectious Diseases Test Volume and DiagnosticsSales Forecast by Market Segment
GermanyLaboratories Performing Infectious Disease TestsForecast by Market Segment
GermanyHospital Laboratories Performing Infectious Disease Tests by Bed Size
GermanyCommercial/Private Laboratories Performing InfectiousDisease Tests by Annual Test Volume
GermanyAll Market Segments Infectious Disease Test Volume Forecast
List of Tables (continued)
GermanyHospital Laboratories Infectious Disease Test Volume Forecast
GermanyBlood Banks Infectious Disease Test Volume Forecast
GermanyCommercial/Private Laboratories Infectious Disease Test Volume Forecast